Peng Lin

1.6k total citations
72 papers, 1.2k citations indexed

About

Peng Lin is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Peng Lin has authored 72 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pulmonary and Respiratory Medicine, 40 papers in Surgery and 16 papers in Oncology. Recurrent topics in Peng Lin's work include Esophageal Cancer Research and Treatment (33 papers), Lung Cancer Diagnosis and Treatment (25 papers) and Gastric Cancer Management and Outcomes (22 papers). Peng Lin is often cited by papers focused on Esophageal Cancer Research and Treatment (33 papers), Lung Cancer Diagnosis and Treatment (25 papers) and Gastric Cancer Management and Outcomes (22 papers). Peng Lin collaborates with scholars based in China, United States and Germany. Peng Lin's co-authors include Jianhua Fu, Hao‐Xian Yang, Tie-Hua Rong, Xue Hou, Hao Long, Lan-Jun Zhang, Lanjun Zhang, Hong Yang, Kongjia Luo and Jing Wen and has published in prestigious journals such as PLoS ONE, Annals of Surgery and Food Chemistry.

In The Last Decade

Peng Lin

68 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peng Lin China 19 667 509 293 136 88 72 1.2k
Takuma Tsukioka Japan 19 417 0.6× 200 0.4× 268 0.9× 148 1.1× 85 1.0× 104 1.0k
P Lozac’h France 16 1.4k 2.1× 1.6k 3.2× 301 1.0× 138 1.0× 86 1.0× 50 2.0k
Kuan-Yuan Chen Taiwan 18 237 0.4× 206 0.4× 200 0.7× 299 2.2× 90 1.0× 87 1.1k
Takashi Matsubara Japan 19 121 0.2× 482 0.9× 269 0.9× 282 2.1× 227 2.6× 63 1.8k
Liqun Jia China 14 149 0.2× 122 0.2× 155 0.5× 305 2.2× 38 0.4× 68 717
Haruo Ezaki Japan 16 122 0.2× 369 0.7× 267 0.9× 178 1.3× 214 2.4× 70 1.2k
Giovanni Rubino Italy 17 297 0.4× 169 0.3× 45 0.2× 102 0.8× 114 1.3× 43 773
Chung‐Hsin Chen Taiwan 21 266 0.4× 593 1.2× 270 0.9× 455 3.3× 670 7.6× 90 2.0k
Shih‐Chang Chuang Taiwan 20 375 0.6× 505 1.0× 347 1.2× 180 1.3× 22 0.3× 60 1.1k
Chen Yao China 18 376 0.6× 232 0.5× 113 0.4× 172 1.3× 31 0.4× 75 1.0k

Countries citing papers authored by Peng Lin

Since Specialization
Citations

This map shows the geographic impact of Peng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Lin more than expected).

Fields of papers citing papers by Peng Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Lin. The network helps show where Peng Lin may publish in the future.

Co-authorship network of co-authors of Peng Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Lin. A scholar is included among the top collaborators of Peng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Lin. Peng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Yi, Lei Wu, Gang Wan, et al.. (2024). Neoadjuvant chemoradiotherapy for T3N0M0 esophageal squamous cell carcinoma. 2(3). 3821–3821.
3.
4.
Han, Ping, et al.. (2023). Comparison of conventional and endoscope-assisted partial superficial parotidectomy for benign neoplasms of the parotid gland: a matched case–control study. International Journal of Oral and Maxillofacial Surgery. 53(3). 199–204. 1 indexed citations
5.
Wang, Zhen, Han Yang, Bin Luo, Pengfei Duan, & Peng Lin. (2022). NFE2L3 as a Novel Biomarker Associated With IL-2/STAT5/NLRP3 Signaling Pathway in Malignant Pleural Mesothelioma and Other Cancers. Frontiers in Genetics. 13. 805256–805256. 2 indexed citations
6.
Hou, Xue, Zheng Tan, Hao Long, et al.. (2022). Who are the real high-risk patients with pathological T2N0M0 non-small-cell lung cancer that can benefit from adjuvant chemotherapy?. ESMO Open. 7(3). 100508–100508. 5 indexed citations
7.
Li, Bob T., Jietian Jin, Valerie W. Rusch, et al.. (2021). Modification of Pathologic T Classification for Non-small Cell Lung Cancer With Visceral Pleural Invasion. CHEST Journal. 160(2). 754–764. 14 indexed citations
8.
9.
10.
He, Yuanfang, Peng Lin, Yanhong Huang, et al.. (2017). Blood cadmium levels associated with short distant metastasis-free survival time in invasive breast cancer. Environmental Science and Pollution Research. 24(36). 28055–28064. 17 indexed citations
11.
Hou, Xue, Jin-Chang Wei, Jianhua Fu, et al.. (2015). Vascular Endothelial Growth Factor is a Useful Predictor of Postoperative Distant Metastasis and Survival Prognosis in Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 22(11). 3666–3673. 10 indexed citations
12.
13.
14.
Tan, Zihui, Guowei Ma, Yuqi Meng, et al.. (2013). Validation of the 7th edition American Joint Committee on cancer staging system for esophageal squamous cell carcinoma. Thoracic Cancer. 4(4). 410–415. 2 indexed citations
15.
Yang, Hao, Wenqi Feng, Wei Jin, et al.. (2013). Support vector machine-based nomogram predicts postoperative distant metastasis for patients with oesophageal squamous cell carcinoma. British Journal of Cancer. 109(5). 1109–1116. 25 indexed citations
16.
Lin, Peng. (2012). Clinical study on Aidi injection combined with FOLFOX4 regimen in the treatment of advanced colorectal cancer. 4 indexed citations
17.
Hou, Xue, Jin-Chang Wei, Ying Xu, et al.. (2012). The Positive Lymph Node Ratio Predicts Long-Term Survival in Patients with Operable Thoracic Esophageal Squamous Cell Carcinoma in China. Annals of Surgical Oncology. 20(5). 1653–1659. 28 indexed citations
18.
Yang, Hao‐Xian, Ying Xu, Jianhua Fu, et al.. (2010). An Evaluation of the Number of Lymph Nodes Examined and Survival for Node-Negative Esophageal Carcinoma: Data from China. Annals of Surgical Oncology. 17(7). 1901–1911. 58 indexed citations
19.
Yang, Hao‐Xian, Xue Hou, Peng Lin, et al.. (2009). Survival and Risk Factors of Surgically Treated Mediastinal Invasion T4 Non-Small Cell Lung Cancer. The Annals of Thoracic Surgery. 88(2). 372–378. 36 indexed citations
20.
Yang, Hao‐Xian, et al.. (2009). Peripheral Direct Adjacent Lobe Invasion Non-small Cell Lung Cancer Has a Similar Survival to That of Parietal Pleural Invasion T3 Disease. Journal of Thoracic Oncology. 4(11). 1342–1346. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takuma Tsukioka Breakdown of academic impact, for papers by P Lozac’h Breakdown of academic impact, for papers by Kuan-Yuan Chen Breakdown of academic impact, for papers by Takashi Matsubara Breakdown of academic impact, for papers by Liqun Jia Breakdown of academic impact, for papers by Haruo Ezaki Breakdown of academic impact, for papers by Giovanni Rubino Breakdown of academic impact, for papers by Chung‐Hsin Chen Breakdown of academic impact, for papers by Shih‐Chang Chuang Breakdown of academic impact, for papers by Chen Yao
Rankless by CCL
2026